Department for Evidence-based Medicine and Evaluation, Cochrane Austria, University for Continuing Education Krems, Krems, Austria.
Department of Internal Medicine Clinical Hospital Colentina, University of Medicine and Pharmacy "Carol Davila", Bucharest, Romania.
Clin Infect Dis. 2024 Jun 14;78(6):1640-1655. doi: 10.1093/cid/ciae195.
Peripheral intravenous catheters (PIVCs) contribute substantially to the global burden of infections. This systematic review assessed 24 infection prevention and control (IPC) interventions to prevent PIVC-associated infections and other complications.
We searched Ovid MEDLINE, Embase, Cochrane Library, WHO Global Index Medicus, CINAHL, and reference lists for controlled studies from 1 January 1980-16 March 2023. We dually selected studies, assessed risk of bias, extracted data, and rated the certainty of evidence (COE). For outcomes with 3 or more trials, we conducted Bayesian random-effects meta-analyses.
105 studies met our prespecified eligibility criteria, addressing 16 of the 24 research questions; no studies were identified for 8 research questions. Based on findings of low to high COE, wearing gloves reduced the risk of overall adverse events related to insertion compared with no gloves (1 non-randomized controlled trial [non-RCT]; adjusted risk ratio [RR], .52; 95% CI, .33-.85), and catheter removal based on defined schedules potentially resulted in a lower phlebitis/thrombophlebitis incidence (10 RCTs; RR, 0.74, 95% credible interval, .49-1.01) compared with clinically indicated removal in adults. In neonates, chlorhexidine reduced the phlebitis score compared with non-chlorhexidine-containing disinfection (1 RCT; 0.14 vs 0.68; P = .003). No statistically significant differences were found for other measures.
Despite their frequent use and concern about PIVC-associated complications, this review underscores the urgent need for more high-quality studies on effective IPC methods regarding safe PIVC management. In the absence of valid evidence, adherence to standard precaution measures and documentation remain the most important principles to curb PIVC complications.
The protocol was registered in the Open Science Framework (https://osf.io/exdb4).
外周静脉导管(PIVC)在全球感染负担中占很大比重。本系统评价评估了 24 项预防感染和控制(IPC)干预措施,以预防 PIVC 相关感染和其他并发症。
我们在 Ovid MEDLINE、Embase、Cochrane 图书馆、世界卫生组织全球医学索引、CINAHL 和参考列表中搜索了 1980 年 1 月 1 日至 2023 年 3 月 16 日的对照研究。我们对研究进行了双重选择,评估了偏倚风险,提取了数据,并对证据确定性(COE)进行了评级。对于有 3 个或更多试验的结局,我们进行了贝叶斯随机效应荟萃分析。
105 项研究符合我们预先规定的入选标准,涉及 24 个研究问题中的 16 个;有 8 个研究问题没有找到研究。基于低到高 COE 的发现,与不戴手套相比,戴手套可降低与插入相关的总体不良事件风险(1 项非随机对照试验 [非 RCT];调整后的风险比 [RR],0.52;95%置信区间,0.33-0.85),并且基于既定时间表的导管拔除可能导致成人发生静脉炎/血栓性静脉炎的发生率降低(10 项 RCT;RR,0.74,95%可信区间,0.49-1.01),与临床指征拔除相比。在新生儿中,与不含氯己定的消毒相比,氯己定降低了静脉炎评分(1 项 RCT;0.14 与 0.68;P=0.003)。对于其他措施,没有发现统计学上的显著差异。
尽管外周静脉导管经常使用,并且人们对其相关并发症感到担忧,但本综述强调了迫切需要更多高质量的研究来确定安全的外周静脉导管管理的有效感染预防和控制方法。在缺乏有效证据的情况下,遵守标准预防措施和记录仍然是遏制外周静脉导管并发症的最重要原则。
该方案在开放科学框架(https://osf.io/exdb4)中注册。